Evidence map›Paper›PMID 42534701›Full record

ArticlePediatric investigation2026

Emphysema in an 11-month-old boy with alpha-1 antitrypsin deficiency.

Irvin Yi, Rachel Williams, Leela Chandrasekar, Saif Al-Qatarneh

Abstract read
In one paragraph

Article in Pediatric investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Irvin YiYale School of Medicine New Haven Connecticut USA.
Rachel WilliamsDepartment of Pediatrics, Section of General Pediatrics Yale University New Haven Connecticut USA.
Leela ChandrasekarDepartment of Pediatrics, Section of Pulmonology Yale University New Haven Connecticut USA.
Saif Al-QatarnehDepartment of Pediatrics, Section of Pulmonology Yale University New Haven Connecticut USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alpha-1 antitrypsin deficiency (A1ATD) is characterized by reduced levels of protease inhibitor alpha-1 antitrypsin, most commonly manifesting with liver disease in childhood, and/or pulmonary disease starting in the 3rd decade of life. Childhood-onset lung disease in A1ATD has almost never been reported. Case presentation: An 11-month-old boy with a history of neonatal cholestasis and A1ATD phenotype PiZZ presented with prolonged fever of unknown origin. A computed tomography chest was obtained, given continued diagnostic uncertainty and the history of A1ATD, showing paramediastinal right upper lobe consolidation, as well as basilar centrilobular emphysema in the left lower lobe, likely secondary to the patient's A1ATD. The patient had no respiratory symptoms and clinically recovered with antibiotics. Conclusion: Pediatric development of emphysema has been rarely described, and this is the earliest documented case to date at 11 months of age. This is also the first finding of asymptomatic emphysema in childhood A1ATD, demonstrating that disease progression may be chronic and may transition from asymptomatic to symptomatic disease.

Indexed as

Alpha‐1 antitrypsin deficiencyEmphysemaPneumonia

Identifiers

PMID42534701
PMCPMC13421838

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.